Nearly three weeks after Presidents Donald Trump and Xi Jinping made nice in South Korea, the details of the US-China trade ceasefire are still being worked out. The main sticking point is Beijing’s licensing terms for exports of rare earth and other critical materials. Also in today’s Gavekal Technologies Briefing, we consider the possibility that the US might be able to break China’s rare-earths chokehold sooner than expected, and report on the Chinese pharma industry’s struggle to generate profits.